Novartis AG Current Ratio 2006-2019 | NVS
Current and historical current ratio for Novartis AG (NVS) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Novartis AG current ratio for the three months ending September 30, 2019 was 0.95.
| Novartis AG Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2019-09-30 |
$26.68B |
$28.22B |
0.95 |
| 2019-06-30 |
$28.32B |
$30.11B |
0.94 |
| 2019-03-31 |
$52.45B |
$56.13B |
0.93 |
| 2018-12-31 |
$35.56B |
$29.61B |
1.20 |
| 2018-09-30 |
$34.11B |
$28.33B |
1.20 |
| 2018-06-30 |
$32.07B |
$27.94B |
1.15 |
| 2018-03-31 |
$33.05B |
$28.22B |
1.17 |
| 2017-12-31 |
$28.21B |
$23.40B |
1.21 |
| 2017-09-30 |
$27.47B |
$25.38B |
1.08 |
| 2017-06-30 |
$26.54B |
$26.15B |
1.02 |
| 2017-03-31 |
$25.77B |
$26.33B |
0.98 |
| 2016-12-31 |
$24.93B |
$22.21B |
1.12 |
| 2016-09-30 |
$25.88B |
$24.60B |
1.05 |
| 2016-06-30 |
$23.72B |
$26.27B |
0.90 |
| 2016-03-31 |
$22.99B |
$27.82B |
0.83 |
| 2015-12-31 |
$22.85B |
$23.71B |
0.96 |
| 2015-09-30 |
$24.05B |
$28.16B |
0.85 |
| 2015-06-30 |
$24.75B |
$29.39B |
0.84 |
| 2015-03-31 |
$25.71B |
$29.05B |
0.89 |
| 2014-12-31 |
$37.56B |
$26.97B |
1.39 |
| 2014-09-30 |
$36.79B |
$26.62B |
1.38 |
| 2014-06-30 |
$34.97B |
$27.56B |
1.27 |
| 2014-03-31 |
$29.69B |
$24.76B |
1.20 |
| 2013-12-31 |
$30.54B |
$26.37B |
1.16 |
| 2013-09-30 |
$28.77B |
$25.81B |
1.12 |
| 2013-06-30 |
$26.85B |
$24.39B |
1.10 |
| 2013-03-31 |
$26.80B |
$26.37B |
1.02 |
| 2012-12-31 |
$28.00B |
$24.05B |
1.16 |
| 2012-09-30 |
$26.15B |
$21.86B |
1.20 |
| 2012-06-30 |
$26.12B |
$24.92B |
1.05 |
| 2012-03-31 |
$25.79B |
$27.36B |
0.94 |
| 2011-12-31 |
$24.08B |
$23.15B |
1.04 |
| 2011-09-30 |
$25.56B |
$25.83B |
0.99 |
| 2011-06-30 |
$26.63B |
$29.54B |
0.90 |
| 2011-03-31 |
$29.10B |
$32.22B |
0.90 |
| 2010-12-31 |
$26.69B |
$24.66B |
1.08 |
| 2010-09-30 |
$27.72B |
$27.66B |
1.00 |
| 2010-06-30 |
$38.67B |
$17.83B |
2.17 |
| 2010-03-31 |
$35.80B |
$17.43B |
2.05 |
| 2009-12-31 |
$33.69B |
$19.47B |
1.73 |
| 2009-09-30 |
$30.44B |
$17.90B |
1.70 |
| 2009-06-30 |
$27.17B |
$15.36B |
1.77 |
| 2009-03-31 |
$22.48B |
$14.99B |
1.50 |
| 2008-12-31 |
$20.88B |
$16.50B |
1.27 |
| 2008-09-30 |
$23.30B |
$19.95B |
1.17 |
| 2008-06-30 |
$32.09B |
$19.68B |
1.63 |
| 2008-03-31 |
$26.29B |
$17.06B |
1.54 |
| 2007-12-31 |
$27.43B |
$16.64B |
1.65 |
| 2007-09-30 |
$28.68B |
$17.50B |
1.64 |
| 2007-06-30 |
$23.98B |
$17.66B |
1.36 |
| 2007-03-31 |
$21.33B |
$17.55B |
1.22 |
| 2006-12-31 |
$21.40B |
$16.23B |
1.32 |
| 2006-09-30 |
$20.97B |
$16.32B |
1.29 |
| 2006-06-30 |
$19.80B |
$16.76B |
1.18 |
| 2006-03-31 |
$21.92B |
$15.59B |
1.41 |
| 2005-12-31 |
$21.44B |
$15.33B |
1.40 |
| 2005-09-30 |
$18.48B |
$12.35B |
1.50 |
| 2005-06-30 |
$20.11B |
$12.54B |
1.60 |
| 2005-03-31 |
$22.26B |
$11.22B |
1.99 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$219.852B |
$51.900B |
|
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.
|
